0001193125-26-398015 Sample Contracts

HALOZYME THERAPEUTICS, INC. and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee INDENTURE Dated as of September 22, 2026 1.50% Convertible Senior Notes due 2033

Indenture • September 22nd, 2026 • Halozyme Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Indenture
• Filed
  September 22nd, 2026
• Company
  Halozyme Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

INDENTURE, dated as of September 22, 2026, between Halozyme Therapeutics, Inc., a Delaware corporation, as issuer (the “Company”), and The Bank of New York Mellon Trust Company, N.A., not in its individual capacity but solely as trustee, registrar, paying agent and conversion agent (the “Trustee”).